BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 29337773)

  • 1. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
    Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
    Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local Excision Versus Radical Resection for 1- to 2-cm Neuroendocrine Tumors of the Rectum: A National Cancer Database Analysis.
    Fields AC; Saadat LV; Scully RE; Davids JS; Goldberg JE; Bleday R; Melnitchouk N
    Dis Colon Rectum; 2019 Apr; 62(4):417-421. PubMed ID: 30394988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcome of Small, Incidentally Detected Rectal Neuroendocrine Tumors Removed by Simple Excisional Biopsy Compared With the Advanced Endoscopic Resection During Screening Colonoscopy.
    Kwak MS; Chung SJ; Yang JI; Im JP; Park MJ; Lee C; Kim JS
    Dis Colon Rectum; 2018 Mar; 61(3):338-346. PubMed ID: 29369898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Distal Resection Margin of ≤1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery: The Role of a Positive Distal Margin in Rectal Cancer Surgery.
    Zeng WG; Liu MJ; Zhou ZX; Wang ZJ
    Dis Colon Rectum; 2017 Nov; 60(11):1175-1183. PubMed ID: 28991082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
    Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
    Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.
    Sasaki T; Ito Y; Ohue M; Kanemitsu Y; Kobatake T; Ito M; Moriya Y; Saito N
    Dis Colon Rectum; 2017 Sep; 60(9):914-921. PubMed ID: 28796729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
    Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
    Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short- and Long-term Outcomes of Laparoscopic Total Mesenteric Excision for Neuroendocrine Tumors of the Rectum.
    Takatsu Y; Fukunaga Y; Nagasaki T; Akiyoshi T; Konishi T; Fujimoto Y; Nagayama S; Ueno M
    Dis Colon Rectum; 2017 Mar; 60(3):284-289. PubMed ID: 28177990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of rectal neuroendocrine tumors ≤ 10 mm following endoscopic resection.
    Kim GU; Kim KJ; Hong SM; Yu ES; Yang DH; Jung KW; Ye BD; Byeon JS; Myung SJ; Yang SK; Kim JH
    Endoscopy; 2013 Dec; 45(12):1018-23. PubMed ID: 24288222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Anal Versus Rectal Staging in the Prognostication of Rectal Squamous Cell Carcinoma: A Population-Based Analysis.
    Goffredo P; Robinson TJ; Frakes JM; Utria AF; Scott AT; Hassan I
    Dis Colon Rectum; 2019 Mar; 62(3):302-308. PubMed ID: 30398999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumors.
    Chi Y; Du F; Zhao H; Wang JW; Cai JQ
    World J Gastroenterol; 2014 Nov; 20(43):16252-7. PubMed ID: 25473180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection.
    Patel SA; Chen YH; Hornick JL; Catalano P; Nowak JA; Zukerberg LR; Bleday R; Shellito PC; Hong TS; Mamon HJ
    Dis Colon Rectum; 2014 Apr; 57(4):449-59. PubMed ID: 24608301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
    Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
    J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
    Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
    J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer.
    Oh BY; Yun HR; Kim SH; Yun SH; Kim HC; Lee WY; Chun HK; Cho YB
    Dis Colon Rectum; 2015 Nov; 58(11):1041-7. PubMed ID: 26445176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circumferential margin involvement after total mesorectal excision for mid or low rectal cancer: are all R1 resections equal?
    Beaufrère A; Guedj N; Maggiori L; Patroni A; Bedossa P; Panis Y
    Colorectal Dis; 2017 Nov; 19(11):O377-O385. PubMed ID: 28941054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
    Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ki-67 labeling index and lymphatic/venous permeation predict the metastatic potential of rectal neuroendocrine tumors.
    Sugimoto S; Hotta K; Shimoda T; Imai K; Yamaguchi Y; Nakajima T; Oishi T; Mori K; Takizawa K; Kakushima N; Tanaka M; Kawata N; Matsubayashi H; Ono H
    Surg Endosc; 2016 Oct; 30(10):4239-48. PubMed ID: 26718357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Clinical Outcomes of Rectal Neuroendocrine Tumors According to the Pathologic Status After Initial Endoscopic Resection: A KASID Multicenter Study.
    Moon CM; Huh KC; Jung SA; Park DI; Kim WH; Jung HM; Koh SJ; Kim JO; Jung Y; Kim KO; Kim JW; Yang DH; Shin JE; Shin SJ; Kim ES; Joo YE
    Am J Gastroenterol; 2016 Sep; 111(9):1276-85. PubMed ID: 27377520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.